Table 1.
Characteristics of study participants (n=519)
| Characteristic | Curative treatment initiated n = 284 | Curative treatment not initiated n = 235 | |
|---|---|---|---|
| HIV status | Uninfected | 84 (29.6%) | 78 (33.2%) |
| Infected | 200 (70.4%) | 157 (66.8%) | |
| Age in years, median (IQR) | 48 (42–57) | 49 (42–62) | |
| Age | ≤ 40 years | 58 (20.4%) | 53 (22.5%) |
| 41–50 years | 113 (39.8%) | 78 (33.2%) | |
| 51–60 years | 64 (22.5%) | 39 (16.6%) | |
| ≥ 61 years | 49 (17.3%) | 65 (27.7%) | |
| Marital status | Single | 169 (59.5%) | 152 (64.7%) |
| Married/partnered | 78 (27.5%) | 52 (22.1%) | |
| Divorced/widowed | 37 (13.0%) | 31 (13.2%) | |
| Stage | Stage 1, 2 | 183 (64.4%) | 65 (27.7%) |
| Stage 3, 4 | 98 (34.5%) | 129 (54.9%) | |
| Missing | 3 (1.1%) | 41 (17.4%) | |
| Baseline hemoglobin, g/dL | < 10 | 85 (29.9%) | 105 (44.7%) |
| ≥ 10 | 199 (70.1%) | 130 (55.3%) | |
| Baseline creatinine, μmol/L, median (IQR) | 54 (46.5–63) | 66.2 (50–87) | |
| Performance status | ≤ 80 | 50 (17.6%) | 61 (26.0%) |
| > 80 | 234 (82.4%) | 174 (74.0%) | |
| On ART* | Yes | 187 (94.9%) | 145 (92.9%) |
| No | 10 (5.1%) | 11 (7.1%) | |
| Baseline CD4 cells/μL, median (IQR)* | 484.0 (342.0–611.0) | 476.5 (308.0–649.5) | |
| Baseline CD4 cells/μL* | < 200 | 10 (%) | 15 (%) |
| 200–349 | 34 (%) | 20 (%) | |
| 350–499 | 45 (%) | 23 (%) | |
| ≥ 500 | 82 (%) | 50 (%) | |
| Distance in km, median (IQR) | 271 (68–410) | 271 (68–410) |
Abbreviations: ART=anti-retroviral treatment; IQR=Interquartile range
*
Only applicable to participants with HIV.